New Peanut Allergy Drug Shows Unprecedented Success New Peanut Allergy Drug Shows Unprecedented Success

Two-thirds of children and adolescents could tolerate two peanuts after a year of immunotherapy, results from the phase 3 PALISADE study show, which could protect them from accidental ingestion.Medscape Medical News (Source: Medscape Medical News Headlines)

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2TpQiYJ